Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
California ‘SARMs’ Business Doesn’t Fool FDA Stating ‘Research Only’ On Supplement Labels
Jun 21 2023
•
By
Malcolm Spicer
• Source: Shutterstock/HBW Insight
More from Regulation
More from Policy & Regulation